MG
Michelle Gilson Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Vir Biotechnology
VIR
$728M
| $5.24 | $20 |
282%
upside
| Overweight |
9 Jan ‘25
8 months ago |
|
2
Q32 Bio
QTTB
$21.7M
| $1.78 | $126 |
6,979%
upside
| Buy |
6 Apr ‘22
3 years ago |
|
3
Corcept Therapeutics
CORT
$7.56B
| $71.73 | $30 |
58%
downside
| Buy |
2 Feb ‘22
3 years ago |
|
4
Rezolute
RZLT
$703M
| $8.08 | $17 |
110%
upside
| Buy |
29 Nov ‘21
3 years ago |
|
5
Ascendis Pharma
ASND
$12.3B
| $202.91 | $196 |
3%
downside
| Buy |
1 Jun ‘21
4 years ago |
|
6
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $45 |
108%
upside
| Buy |
27 May ‘21
4 years ago |
|
7
Stoke Therapeutics
STOK
$1.21B
| $22.07 | $76 |
244%
upside
| Buy |
11 Mar ‘21
4 years ago |
|
8
BioMarin Pharmaceuticals
BMRN
$10.7B
| $55.69 | $91 |
63%
upside
| Buy |
1 Mar ‘21
4 years ago |
|